Home/BioArctic AB/Erika Otterström-Lindblad
EO

Erika Otterström-Lindblad

Chief Operating Officer

BioArctic AB

BioArctic AB Pipeline

DrugIndicationPhase
Lecanemab (Leqembi®)Early Alzheimer's DiseaseApproved
BAN2802Alzheimer's DiseasePreclinical
Lecanemab SCAlzheimer's DiseasePhase 3
ABBV-0805Parkinson's DiseasePhase 1
BAN1202Parkinson's DiseasePreclinical